메뉴 건너뛰기




Volumn 8, Issue 3, 2012, Pages 149-152

Biochemical markers in osteoporosis: Usefulness in clinical practice;Marcadores bioquímicos en osteoporosis. Utilidad en la práctica clínica

Author keywords

Biochemical markers; Biological variability; Fracture; Osteoporosis

Indexed keywords

BIOCHEMICAL MARKER;

EID: 84860532504     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2011.05.010     Document Type: Article
Times cited : (36)

References (34)
  • 2
    • 0034879092 scopus 로고    scopus 로고
    • Role of biochemical markers in the management of osteoporosis
    • Ebeling P., Akesson K. Role of biochemical markers in the management of osteoporosis. Best Pract Res Clin Rheumatol 2001, 15:385-400.
    • (2001) Best Pract Res Clin Rheumatol , vol.15 , pp. 385-400
    • Ebeling, P.1    Akesson, K.2
  • 3
    • 55049115074 scopus 로고    scopus 로고
    • Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis
    • Szulc P., Delmas P. Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int 2008, 19:1683-1704.
    • (2008) Osteoporos Int , vol.19 , pp. 1683-1704
    • Szulc, P.1    Delmas, P.2
  • 4
    • 36049009800 scopus 로고    scopus 로고
    • Biochemical markers of bone turnover
    • En: Murray J. Favus, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 6.a ed. Washington: American Society for Bone and Mineral Research
    • Camacho P, Kleerekoper M. Biochemical markers of bone turnover. En: Murray J. Favus, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 6.a ed. Washington: American Society for Bone and Mineral Research; 2006. p. 127-33.
    • (2006) , pp. 127-33
    • Camacho, P.1    Kleerekoper, M.2
  • 5
    • 0034526072 scopus 로고    scopus 로고
    • Committee of Scientific Advisors of the International. Osteoporosis Foundation. The use of biochemical markers of bone turnover in osteoporosis
    • Delmas P.D., Eastell R., Garnero P., Seibel M.J., Stepan J. Committee of Scientific Advisors of the International. Osteoporosis Foundation. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 2000, 11(Suppl 6):2-17.
    • (2000) Osteoporos Int , vol.11 , Issue.SUPPL. 6 , pp. 2-17
    • Delmas, P.D.1    Eastell, R.2    Garnero, P.3    Seibel, M.J.4    Stepan, J.5
  • 6
    • 0036273146 scopus 로고    scopus 로고
    • Effect of feeding on bone turnover markers and its impact on biological variability of measurements
    • Clowes J.A., Hannon R.A., Yap T.S., Hoyle N.R., Blumsohn A., Eastell R. Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 2002, 30:886-890.
    • (2002) Bone , vol.30 , pp. 886-890
    • Clowes, J.A.1    Hannon, R.A.2    Yap, T.S.3    Hoyle, N.R.4    Blumsohn, A.5    Eastell, R.6
  • 9
    • 0029799613 scopus 로고    scopus 로고
    • Molecular basis and clinical application of biological markers of bone turnover
    • Calvo M.S., Eyre D., Gundberg C.M. Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 1996, 17:333-368.
    • (1996) Endocr Rev , vol.17 , pp. 333-368
    • Calvo, M.S.1    Eyre, D.2    Gundberg, C.M.3
  • 12
    • 0041684564 scopus 로고
    • Correlación entre el telopéptido carboxiterminal del colágeno tipo I y la densidad mineral ósea medida por DEXA en la osteoporosis postmenopáusica
    • De la Piedra C., Díaz M.A. Correlación entre el telopéptido carboxiterminal del colágeno tipo I y la densidad mineral ósea medida por DEXA en la osteoporosis postmenopáusica. REEMO 1992, 1(Suppl B):30.
    • (1992) REEMO , vol.1 , Issue.SUPPL. B , pp. 30
    • De la Piedra, C.1    Díaz, M.A.2
  • 13
    • 60549085579 scopus 로고    scopus 로고
    • New biochemical markers of bone turnover
    • Garnero P. New biochemical markers of bone turnover. IBMS Bonekey 2008, 5:84-102.
    • (2008) IBMS Bonekey , vol.5 , pp. 84-102
    • Garnero, P.1
  • 15
    • 0036317378 scopus 로고    scopus 로고
    • A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients
    • Srivastava A.K., Mohan S., Singer F.R., Baylink D.J. A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients. Bone 2002, 31:62-69.
    • (2002) Bone , vol.31 , pp. 62-69
    • Srivastava, A.K.1    Mohan, S.2    Singer, F.R.3    Baylink, D.J.4
  • 16
    • 58249087512 scopus 로고    scopus 로고
    • Utilidad clínica de los marcadores bioquímicos de remodelado óseo en la mujer posmenopáusica reciente: estudio longitudinal a 2 años
    • Navarro L., Blázquez J.A., Del Pino J., Almar R., Cháfer M., Mateos F. Utilidad clínica de los marcadores bioquímicos de remodelado óseo en la mujer posmenopáusica reciente: estudio longitudinal a 2 años. Med Clin (Barc) 2008, 131:333-338.
    • (2008) Med Clin (Barc) , vol.131 , pp. 333-338
    • Navarro, L.1    Blázquez, J.A.2    Del Pino, J.3    Almar, R.4    Cháfer, M.5    Mateos, F.6
  • 18
    • 0028586042 scopus 로고
    • Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment
    • Garnero P., Shih W.J., Gineyts E., Karpf D.B., Delmos P.D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Matab 1994, 79:1693-1700.
    • (1994) J Clin Endocrinol Matab , vol.79 , pp. 1693-1700
    • Garnero, P.1    Shih, W.J.2    Gineyts, E.3    Karpf, D.B.4    Delmos, P.D.5
  • 19
    • 0030664688 scopus 로고    scopus 로고
    • Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
    • Delmas P.D., Bjarnason N.H., Mitlak B.H., Ravoux A.C., Shah A.S., Huster W.J., et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997, 337:1641-1647.
    • (1997) N Engl J Med , vol.337 , pp. 1641-1647
    • Delmas, P.D.1    Bjarnason, N.H.2    Mitlak, B.H.3    Ravoux, A.C.4    Shah, A.S.5    Huster, W.J.6
  • 20
    • 54849410645 scopus 로고    scopus 로고
    • Using biochemical markers of bone turnover in clinical practice
    • Singe M.D., Frederick R., Eyre D., David R. Using biochemical markers of bone turnover in clinical practice. Cleve Clin J Med 2008, 75:739-750.
    • (2008) Cleve Clin J Med , vol.75 , pp. 739-750
    • Singe, M.D.1    Frederick, R.2    Eyre, D.3    David, R.4
  • 21
    • 19044364417 scopus 로고    scopus 로고
    • Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis
    • Chen P., Satterwhite J.H., Licata A.A., Lewiecki E.M., Sipos A.A., Misurski D.M., et al. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. J Bone Miner Res 2005, 20:962-970.
    • (2005) J Bone Miner Res , vol.20 , pp. 962-970
    • Chen, P.1    Satterwhite, J.H.2    Licata, A.A.3    Lewiecki, E.M.4    Sipos, A.A.5    Misurski, D.M.6
  • 22
    • 30844433757 scopus 로고    scopus 로고
    • Reginster J-Y. Development of an algorithm for using PINP to monitor treatment of patients with teriparatide
    • Eastell R., Krege J.H., Chen P., Glass E.V. Reginster J-Y. Development of an algorithm for using PINP to monitor treatment of patients with teriparatide. Curr Med Res Opin 2006, 22:61-66.
    • (2006) Curr Med Res Opin , vol.22 , pp. 61-66
    • Eastell, R.1    Krege, J.H.2    Chen, P.3    Glass, E.V.4
  • 23
    • 0029923080 scopus 로고    scopus 로고
    • Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy
    • Riggs B.L., Melton L.J., Oófallon W.M. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone 1996, 18:197-201.
    • (1996) Bone , vol.18 , pp. 197-201
    • Riggs, B.L.1    Melton, L.J.2    Oófallon, W.M.3
  • 24
    • 0036284616 scopus 로고    scopus 로고
    • Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents
    • Hochberg M.C., Greenspan S., Wasnich R.D., Miller P., Thompson D.E., Ross P.D. Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 2002, 87:1587-1589.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 1587-1589
    • Hochberg, M.C.1    Greenspan, S.2    Wasnich, R.D.3    Miller, P.4    Thompson, D.E.5    Ross, P.D.6
  • 25
    • 23044456161 scopus 로고    scopus 로고
    • Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy
    • Dobnig H., Sipos A., Jiang Y., Fahrleitner A., Ste-Marie L.G., Gallagher J.C., et al. Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy. J Clin Endocrinol Metab 2005, 90:3970-3977.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 3970-3977
    • Dobnig, H.1    Sipos, A.2    Jiang, Y.3    Fahrleitner, A.4    Ste-Marie, L.G.5    Gallagher, J.C.6
  • 26
    • 0034065559 scopus 로고    scopus 로고
    • Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib
    • Mashiba T., Hirano T., Turner C.H., Forwood M.R., Johston C.C., Burr D.B. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 2000, 15:613.
    • (2000) J Bone Miner Res , vol.15 , pp. 613
    • Mashiba, T.1    Hirano, T.2    Turner, C.H.3    Forwood, M.R.4    Johston, C.C.5    Burr, D.B.6
  • 27
    • 0003062649 scopus 로고    scopus 로고
    • Hormone replacement therapy in postmenopausal women: urinary n-telopeptide of type i collagen monitors therapeutic effect and predicts response of bone mineral density
    • Chesnut C.H., Bell M.D., Clark M.D., Drinkwater P.B., English M.D.S.C., Johnston C.C., et al. Hormone replacement therapy in postmenopausal women: urinary n-telopeptide of type i collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med 1997, 102:29-37.
    • (1997) Am J Med , vol.102 , pp. 29-37
    • Chesnut, C.H.1    Bell, M.D.2    Clark, M.D.3    Drinkwater, P.B.4    English, M.D.S.C.5    Johnston, C.C.6
  • 28
    • 1642397685 scopus 로고    scopus 로고
    • Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate
    • Seibel M.J., Naganathan V., Barton I., Grauer A. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate. J Bone Miner Res 2004, 19:323-329.
    • (2004) J Bone Miner Res , vol.19 , pp. 323-329
    • Seibel, M.J.1    Naganathan, V.2    Barton, I.3    Grauer, A.4
  • 29
    • 44449146096 scopus 로고    scopus 로고
    • Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring
    • Garnero P. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Molecular Diagnosis & Therapy 2008, 12:157-170.
    • (2008) Molecular Diagnosis & Therapy , vol.12 , pp. 157-170
    • Garnero, P.1
  • 31
    • 0031937226 scopus 로고    scopus 로고
    • Rapid bone loss is associated with increased levels of biochemical markers
    • Ross P.D., Knowlton W. Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 1998, 13:297-302.
    • (1998) J Bone Miner Res , vol.13 , pp. 297-302
    • Ross, P.D.1    Knowlton, W.2
  • 32
    • 42149165521 scopus 로고    scopus 로고
    • Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis
    • Vasikaran S.D. Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis. Crit Rev Clin Lab Sci 2008, 45:221-258.
    • (2008) Crit Rev Clin Lab Sci , vol.45 , pp. 221-258
    • Vasikaran, S.D.1
  • 33
    • 18244383320 scopus 로고    scopus 로고
    • Assesment nad recommendations on factors contributing to preanalytical variability of urinary pyridinolina and deoxypiridinolina
    • Vesper H.W., Demers L.M., Eastell R., Garnero P., Kleerokoper M., Robins S.P., et al. Assesment nad recommendations on factors contributing to preanalytical variability of urinary pyridinolina and deoxypiridinolina. Clin Chem 2002, 48:220-235.
    • (2002) Clin Chem , vol.48 , pp. 220-235
    • Vesper, H.W.1    Demers, L.M.2    Eastell, R.3    Garnero, P.4    Kleerokoper, M.5    Robins, S.P.6
  • 34
    • 0033197068 scopus 로고    scopus 로고
    • Practical clinical application of biochemical markers of bone turnover
    • Miller P.D., Baran D.T. Practical clinical application of biochemical markers of bone turnover. J Clin Densitometry 1999, 2:323-342.
    • (1999) J Clin Densitometry , vol.2 , pp. 323-342
    • Miller, P.D.1    Baran, D.T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.